 Effective thrombolysis plasminemia intravenous administration vampire bat salivary plasminogen activator rabbits BACKGROUND use recombinant tissue-type plasminogen activator t-PA thrombolytic therapy significant fibrinogenolysis contrast recombinant vampire bat salivary plasminogen activator Bat-PA strict fibrin specificity attribute desirable fibrinolytic agent METHODS RESULTS efficacy fibrin selectivity Bat-PA t-PA rabbit model femoral arterial thrombosis Administration nmol Bat-PA/kg intravenous injection flow rabbits incidence reperfusion intravenous injection nmol t-PA/kg maximal femoral artery reperfusion flows equivalent treatment nmol Bat-PA/kg nmol t-PA/kg time maximal flow Bat-PA half t-PA rapid restoration flow nmol Bat-PA/kg contrast t-PA fibrinogenolysis small decreases plasminogen alpha levels Equipotent doses Bat-PA t-PA approximate increases template times aspirin-pretreated rabbits clearance Bat-PA rabbits biexponential elimination kinetics slow beta phase half-life minutes Overall Bat-PA fourfold t-PA CONCLUSIONS Bolus intravenous administration Bat-PA prompt initiation thrombolytic therapy avoidance plasminemia severe bleeding complications